Influenza virus vaccine, quadrivalent (Seqirus)

N/A

Report date: 2024/12/12 17:10:39

Base Information

Drug NameInfluenza virus vaccine, quadrivalent (Seqirus)
Drug Alias NameAdjuvanted quadrivalent influenza vaccine(Seqirus)Adjuvanted quadrivalent influenza vaccine surface antigen inactivated(Seqirus)Adjuvanted quadrivalent subunit influenza virus vaccine (Seqirus)aQIIaQIV(Seqirus) +[16] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Global Approved IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2016/08/26
Country/TerritoryCzechiaBelgiumBulgaria +[26] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSeqirus
China Registration ClassN/A

Develop Information

Active CompaniesSeqirus
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB01
Related LinksN/A